Oasmia Incentive AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Per Langö, was filed 18 Oct 2017.
Oasmia Incentive AB: what insiders have been doing
Oasmia Incentive AB is a listed company. Its directors and officers file their transactions with Finansinspektionen. Oasmia Incentive AB has had no insider filing for more than a year; the last one goes back to 18 October 2017.
Since 2016, the database holds 2 purchases and no sales by insiders of the company.
For comparison within the same market, see the insider buying recorded at Dynavox Group AB and Rusta AB (publ). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Financial data
· cache
- 750,000 shares@ SEK 0.17100.0% of flowFI:csv-bfc1643a67d55076f25eCanonical exit: 14 Jan 2018 (T+90)
- 4,000,000 shares@ SEK 0.37100.0% of flowFI:csv-89491e6ecc4de626b8fdCanonical exit: 13 Mar 2017 (T+90)
2 of 2 declarations
About Oasmia Incentive AB
Oasmia Incentive AB is a company listed on the XSTO market, specializing in the development of oncology treatments. It focuses on innovation in cancer medication.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations